Patents Assigned to SYNERGIA LIFE SCIENCES PVT. LTD.
  • Process for stereospecific synthesis of vitamin K2 and its novel intermediates
    Patent number: 11912654
    Abstract: The present disclosure relates to a novel process for the synthesis of stereospecific compounds of Vitamin K2 group in general and Vitamin K2-7. The present disclosure further discloses novel intermediates useful in the synthesis of stereospecific Vitamin K2-7. Compounds of the Vitamin K2 group obtained are crystalline and exhibit well defined melting points.
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: February 27, 2024
    Assignee: SYNERGIA LIFE SCIENCES PVT. LTD.
    Inventors: Dilip Mehta, Mayank Shashtri, BNS Raju, Ashwin Shah, Parin Vora, Umakant Mahale
  • Vitamin K2 compositions for the treatment of drug induced neuropathy
    Patent number: 11628147
    Abstract: The present invention provides the use of vitamin K2 compositions for the treatment of drug-induced neuropathy. More particularly it is related to the use of vitamin K2-7 compositions for the treatment of drug-induced peripheral neuropathy caused by the drugs used for the treatment of multiple myeloma.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: April 18, 2023
    Assignee: SYNERGIA LIFE SCIENCES PVT. LTD.
    Inventors: Dilip Mehta, Ashok Vaidya, Rama Vaidya, Yogesh Dound, Anselm De Souza